Therefore, we aimed to analyze PSMA expression by immunohistochemical staining (IHC) in glioma tissues and to relate the observed PSMA expression to tumor metabolism measured by MET PET and survival in a large, treatment-naïve glioma cohort. This evidence concerns the gene FOLH1 and central nervous system cancer.